Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectGlobal Markets for Treatments for Syndromes of Dementia and Movem...
The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.
Global Markets for Asthma and COPD Drugs
The global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is projected to reach $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 4.4%.
Genitourinary Drugs: Technologies and Global Markets
The total market for genitourinary drugs is projected to increase from $26.5 billion in 2011 to $30.7 billion in 2016 at a compound annual growth rate (CAGR) of 3% for a period of five years, from 2011 to 2016.
Drugs for Treating Congestive Heart Failure: Global Markets
The global market for congestive heart failure pharmaceuticals was valued at nearly $11.2 billion in 2010. This market is expected to reach nearly $12.2 billion in 2011 and $18.6 billion in 2016, a compound annual growth rate (CAGR) of 8.9% between 2011 and 2016.
Global Markets for Marine-Derived Pharmaceuticals
The global market for marine-derived drugs by type was around $4.8 billion in 2011, which is expected to be around $5.3 billion in 2012. This global market is forecasted to reach $8.6 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% for the five year period of 2011 to 2016.
Markets for Emerging Pharmaceutical Technologies
As a segment, therapeutic vaccines recorded $19.3 billion in 2010, a figure that is expected to grow to $31.9 billion by 2015, demonstrating a compound annual growth rate (CAGR) of 10.6%.
Emerging Regional Markets for Therapeutic Drugs
The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa. These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.
The Clinical Trials Business
New technologies and the outsourcing of clinical trials to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014.
Therapeutic Drugs for Central Nervous System (CNS) Disorders: Tec...
This study provides a comprehensive analysis of central nervous system therapies on a global basis. It provides a range of information, from detailed product analyses within disease sub-segments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the central nervous system sector.
Oncology Adjuvants: Technologies and Global Markets
This report covers the current status of the global oncolytic adjuvant marketplace and assess its growth potential over the five-year period from 2010 to 2015
Cardiovascular Therapeutic Drugs: Technologies and Global Markets
This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the cardiovascular segment. Includes forecasts through 2015
Osteoporosis Drugs: Technologies and Global Markets
This study describes the industry structure and major participants in the osteoporosis drugs market, market dynamics and competitive aspects, current developments and future market trends, to assist in understanding the market and identifying areas of commercial interest and potential in osteoporosis. Includes forecasts through 2014
Autacoids and Related Drugs: Technologies and Global Markets
This BCC report presents a comprehensive analysis of the current market for autacoids and related drugs and its future direction. It also examines the x biologic activity and usage of autacoids in the treatment of various diseases. Includes forecasts through 2015
Therapies for Depressive and Anxiety Disorders
Research report on the Global Market for Therapies for Depressive and Anxiety Disorders. Includes forecasts through 2014
Global Viral Vector Manufacturing Markets and Technologies Through 2030
This report provides an overview and analysis of viral vector manufacturing markets and technologies.
Immunotherapy Drugs: Global Markets
This report will provide detailed information on immunotherapy drugs. This report analyzes the market trends with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025 – 2030), and regional markets.
Targeted Alpha Therapies for Cancer Treatment: Global Market
This report provides an overview of the global market for targeted alpha therapies for cancer and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.
Hyaluronic Acid in Healthcare: Global Markets
This goal of this report is to impart in-depth knowledge of the global market for hyaluronic acid (HA) products, in terms of both qualitative and quantitative data, to help readers assess the market landscape, develop business/growth strategies, and analyze their market position.
Global Artificial Intelligence (AI) in Clinical Trials Market
This report provides an overview of the global AI in clinical trials market. It focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Artificial Intelligence (AI) in Pharmaceuticals: Global Markets
This report provides an overview of the global market for AI in pharmaceuticals. It focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Brain Tumor Therapeutics: Global Markets to 2030
This report provides a detailed information on brain tumor therapeutics. It analyzes the global market trends with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030.
